1. Home
  2. INFU vs MSD Comparison

INFU vs MSD Comparison

Compare INFU & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • MSD
  • Stock Information
  • Founded
  • INFU 2005
  • MSD 1993
  • Country
  • INFU United States
  • MSD United States
  • Employees
  • INFU N/A
  • MSD N/A
  • Industry
  • INFU Medical/Dental Instruments
  • MSD Trusts Except Educational Religious and Charitable
  • Sector
  • INFU Health Care
  • MSD Finance
  • Exchange
  • INFU Nasdaq
  • MSD Nasdaq
  • Market Cap
  • INFU 104.4M
  • MSD 144.6M
  • IPO Year
  • INFU N/A
  • MSD N/A
  • Fundamental
  • Price
  • INFU $5.50
  • MSD $7.44
  • Analyst Decision
  • INFU
  • MSD
  • Analyst Count
  • INFU 0
  • MSD 0
  • Target Price
  • INFU N/A
  • MSD N/A
  • AVG Volume (30 Days)
  • INFU 124.9K
  • MSD 70.2K
  • Earning Date
  • INFU 05-08-2025
  • MSD 01-01-0001
  • Dividend Yield
  • INFU N/A
  • MSD 11.26%
  • EPS Growth
  • INFU 3654.89
  • MSD N/A
  • EPS
  • INFU 0.15
  • MSD N/A
  • Revenue
  • INFU $137,582,000.00
  • MSD N/A
  • Revenue This Year
  • INFU $10.91
  • MSD N/A
  • Revenue Next Year
  • INFU $8.18
  • MSD N/A
  • P/E Ratio
  • INFU $36.63
  • MSD N/A
  • Revenue Growth
  • INFU 7.98
  • MSD N/A
  • 52 Week Low
  • INFU $4.61
  • MSD $6.11
  • 52 Week High
  • INFU $9.97
  • MSD $7.46
  • Technical
  • Relative Strength Index (RSI)
  • INFU 60.31
  • MSD 42.18
  • Support Level
  • INFU $4.67
  • MSD $7.50
  • Resistance Level
  • INFU $4.89
  • MSD $7.62
  • Average True Range (ATR)
  • INFU 0.21
  • MSD 0.12
  • MACD
  • INFU 0.09
  • MSD 0.02
  • Stochastic Oscillator
  • INFU 88.42
  • MSD 45.19

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: